Mesoblast (MESO) FCF Margin (QoQ) (2016 - 2023)
Powered by 
Analysis
Mesoblast (MESO) FCF Margin (QoQ) (2016 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 994,127.00 |
| Mar 31, 2023 | -477,991.00 |
| Dec 31, 2022 | -17,953.00 |
| Sep 30, 2022 | 164,147.00 |
| Jun 30, 2022 | 8,081.00 |
| Mar 31, 2022 | -25,646.00 |
| Dec 31, 2021 | -102,161.00 |
| Sep 30, 2021 | 147,217.00 |
| Jun 30, 2021 | 31,206.00 |
| Mar 31, 2021 | 8,671.00 |
| Dec 31, 2020 | 79,382.00 |
| Mar 31, 2020 | 35,087.00 |
| Dec 31, 2019 | -37,655.00 |
| Mar 31, 2019 | -159,182.00 |
| Dec 31, 2018 | 6,329.00 |
| Sep 30, 2018 | 101,958.00 |
| Jun 30, 2018 | 64,453.00 |
| Mar 31, 2018 | -172,110.00 |
| Dec 31, 2017 | 162,294.00 |
| Sep 30, 2017 | 240,656.00 |